Skip to main content
. Author manuscript; available in PMC: 2018 Nov 1.
Published in final edited form as: Drug Alcohol Depend. 2018 Sep 21;192:186–192. doi: 10.1016/j.drugalcdep.2018.07.045

Figure 3. Treatment by time interaction on ventral striatal RSFC.

Figure 3.

The naltrexone group exhibited reduced connectivity between ventral striatum, amygdala, hippocampus and midbrain between scan 1 and scan 2 (p < 0.05, whole-brain corrected). Parameter estimates (regression β-values) were extracted from the functional ROI of the amygdala and hippocampus.